FDx Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

FDx Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,958	Closed	-$221K	–	846
2021 Q3	$221K	Buy	2,958 +766	+35%	+$64.3K	0.01%	764
2021 Q2	$203K	Buy	+2,192	New	+$186K	0.01%	783
2021 Q1	–	Sell	-6,378	Closed	-$595K	–	767
2020 Q4	$595K	Sell	6,378 -235	-4%	-$18.7K	0.02%	395
2020 Q3	$421K	Buy	+6,613	New	+$388K	0.02%	417
2018 Q2	–	Sell	-42,286	Closed	-$1.09M	–	863
2018 Q1	$1.09M	Buy	+42,286	New	+$1.15M	0.03%	480

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FDx Advisors's ARKG Position: Q4 2021 in Review

FDx Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 2,958 shares — an estimated $221K sold.

FDx Advisors first reported a position in ARKG in Q1 2018 and held it in 5 quarters. The position peaked at $1.09M in Q1 2018. 461 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

FDx Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
FDx Advisors sold 2,958 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $221K.
FDx Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 5 quarters.
FDx Advisors's ARK Genomic Revolution ETF position peaked at $1.09M in Q1 2018.
461 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on FDx Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.